the same period of last year and a decrease of 5.28% over the last quarter . Such decrease was mainly due to dropping in metal price and low level of production and sales. 2. Cost of sales was 384.25

Manager of the Stock Exchange of Thailand For the Q2/2019 period ended of June 30, 2019 (3 months) operating result of the company net loss Baht 6.47 Million comparison with the previous Q2/2018’s net loss

results for the 2nd quarter of 2019 which has variance of over 20 percent comparing to the same period of the previous year. The relevant details are as follows:- “Net earned premium” and “Commission and

same period of last year mainly due to lower aluminium prices.However, when comparing with previous quarter,it was increased 10.5% 2. Cost of sales was 431.57 million Baht or 107.58% of sales which

Analysis for the three-month period ended 31 March 2018 To : Director and the President The Stock Exchange of Thailand Summary of the Company’s Financial Position and Operating Result for the three-month

percent, in which the gross profit margin of the Company has decreased when compared to the same period of last year due to decreasing of The Company’s sales and services revenue but some of manufacturing

same period of last year and an increase of 24.9% over the last quarter . Such increase was mainly due to the increase in aluminium price and the expansion of sales volume from exporting to overseas

/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

Myanmar. Profit for the period L&E’s consolidated profit for the period of Q2/2018 was posted at Baht 24.7 million, up 194% or Baht 16.3 million from a year earlier, which can be summarized as follows: 1

earned premium moreover increased from 58.46% in the same period last year to 60.18% this year because of the fact that the average amount of claim expenses over accident related to voluntary motor